Article
The neurogenomics view of neurological diseases.
JAMA neurology - 1 Jun 2013
Tsuji Shoji
Abstract excerpt
The availability of high-throughput genome sequencing technologies is expected to revolutionize our understanding of not only hereditary neurological diseases but also sporadic neurological diseases. The molecular bases of sporadic diseases, particularly those of sporadic neurodegenerative diseases, largely remain unknown. As potential molecular bases, various mechanisms can be considered, which include those...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
